HR Execs on the Move

Medical Tracking Solutions

www.medicaltracking.com

 
Medical Tracking Solutions, a team of medical device industry experts, developed iTraycer to meet the day-to-day challenges of medical device companies. iTraycer is a comprehensive inventory management system that provides real-time tracking of medical devices and biologics – visible by part, lot, and serial numbers – from manufacturer to patient. The system`s multifunctional software facilitates communication and collaboration across the enterprise and enables companies to make critical, fact-based decisions with real-time information. And, iTraycer ensures compliance by addressing the traceability requirements of Unique Device Identification (UDI) regulations.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Harmac Medical Products

Harmac Medical Products, Inc is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Fortec Medical

The ForTec Laser Rental Program provides medical lasers to hospitals, surgical centers and physicians delivering the latest in therapies and treatments.

MMI Healthcare

MMI Healthcare is a Millersville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IBP MEDICAL

IBP MEDICAL is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Armetheon

Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ability to offer peace of mind to patients while benefitting physicians, who may wish to reduce safety concerns, side effects and adverse events for their patients.